Nagoya University · 의학
Toyofumi F. Chen-Yoshikawa 교수의 연구실은 폐이식의 핵심 과제인 이소화-재순환 손상과 이식 거부반응의 기전 규명을 중심으로, 특히 폐 내피세포의 역할에 초점을 맞춘 기초 및 임상 연구를 수행하고 있습니다. 또한 3D-CT 기반 수술 시뮬레이션, 동적 재건 경로 지도, 인도시민 레이저 영상 유도 수술 기술 등 첨단 수술 보조 기술의 개발을 통해 정확하고 안전한 폐엽 절제술 및 이식 수술의 실현 가능성을 높이고 있습니다. 특히 영상 투사 기반 수술 유도 기술을 활용한 암 전이灶 탐지 및 수술 성과 향상에 대한 응용 연구가 두드러집니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Lung transplantation has been established worldwide as the last treatment for end-stage respiratory failure. However, ischemia-reperfusion injury (IRI) inevitably occurs after lung transplantation. The most severe form of IRI leads to primary graft failure, which is an important cause of morbidity and mortality after lung transplantation. IRI may also induce rejection, which is the main cause of mortality in recipients. Despite advances in donor management and graft preservation, most donor graf
After the introduction of 3D-CT technology to the field of thoracic surgery, preoperative simulation has been developed for various thoracic procedures. In the near future, this technique will become more common in thoracic surgery, and frequent use by thoracic surgeons will be seen in worldwide daily practice.
We successfully developed a novel dynamic simulation system, the Resection Process Map, for anatomic pulmonary resection.
Lung transplantation for pulmonary complications after HSCT was performed safely and yielded better survival, especially in younger recipients for whom both lung transplantation and HSCT involved the same donor.
Indocyanine green fluorescent image-guided surgery was developed to identify primary and metastatic nodules of various malignancies. However, currently, surgeons need to identify the fluorescent image on a monitor, which impedes surgical procedures. Herein, we developed a novel projection mapping device that can cast the real-time fluorescent image onto the surface of the targeted organ. We performed surgical resection of a lung metastasis of hepatoblastoma using this technique. The projection m
Right-to-left inverted LDLLT is a safe and useful option with encouraging intermediate outcome.